11 slides from Radcom's earnings presentation, 2017
Slide 1: Reference Slides: Earnings Call for Q4-16 Results
Reference Slides Earnings Call for Q4-16 Results
Slide 2: Safe Harbor Provision
SAFE HARBOR PROVISION Certain statements made herein that use words such as “estimate,” “project,” “intend,” “expect,” “'believe”, "may", "might", "predict", "potential", "anticipate", "plan" or similar expressions are intended to identify forward- looking statements within the meaning of the Privat
Slide 3: Overview
OVERVIEW Q4 Revenues up 196% YoY to $8M Revenues for the full year 2016 were $29.5M, up 58% compared to full year 2015 2017 Revenue Guidance range of $36-$39 million 3
Slide 4: Financials
FINANCIALS Fourth Quarter and Full Year 2016 Financial Results 4
Slide 5: Income Statement for Q4 and Full Year (GAAP, US$ 1000s)
INCOME STATEMENT FOR Q4 AND FULL YEAR (GAAP, US$ 1000S) Three months ended Twelve months ended December 31, December 31, 2016 2015 2016 2015 Sales 8,037 2,715 29,510 18,673 Cost of sales 2,796 1,137 8,982 4,326 Gross profit 5,241 1,578 20,528 14,347 Gross profit % 65% 58% 70% 77% Research and develo
Slide 6: Income Statement for Q4 and Full Year (Non-GAAP, US$ 1000s)
INCOME STATEMENT FOR Q4 AND FULL YEAR (NON-GAAP, US$ 1000S) Three months ended Twelve months ended December 31, December 31, 2016 2015 2016 2015 NON-GAAP (1) Sales 8,037 2,715 29,510 18,673 Cost of sales 2,371 963 8,476 4,123 Gross profit 5,666 1,752 21,034 14,550 Gross profit % 71% 65% 71% 78% Rese
Slide 7: Operating Expenses (GAAP, US$ 1000s)
OPERATING EXPENSES (GAAP, US$ 1000S) Three months ended Twelve months ended 2016 2015 2016 2015 Research and development, gross 2,594 1,620 8,047 6,071 Less - royalty-bearing participation 552 576 1,693 1,582 Research and development, net 2,042 1,044 6,354 4,489 Sales and marketing, net 2,917 2,054
Slide 8: Operating Expenses (Non GAAP, US$ 1000s)
OPERATING EXPENSES (NON GAAP, US$ 1000S) Three months ended Twelve months ended 2016 2015 2016 2015 NON-GAAP (1) Research and development, gross 2,363 1,524 7,422 5,542 Less - royalty-bearing participation 552 576 1,693 1,582 Research and development, net 1,811 948 5,729 3,960 Sales and marketing, n
Slide 9: Balance Sheet (US$ 1000s)
BALANCE SHEET (US$ 1000S) As of As of December December 31, 2016 31, 2015 Cash and cash equivalents 42,886 8,727 Restricted bank deposits 32 32 Trade Receivables, net 4,388 3,684 Inventories 623 1,532 Other receivables 1,960 2,087 Total Current assets 49,889 16,062 Severance pay fund 2,788 3,181 Oth
Slide 10: Current Assets vs. Current Liabilities
CURRENT ASSETS VS. CURRENT LIABILITIES 60.0 49.9 50.0 40.0 30.0 352% 20.0 16.5 16.1 156% 150% 10.0 11.0 6.4 6.4 0.0 Q4-14 Q4-15 Q4-16 Current Assets Current Liabilities 10